IMRIS announced the initial launch of the world's first Magnetic Resonance-safe and Computed Tomography-compatible horseshoe headrest for the positioning of patients during neurosurgical procedures requiring intraoperative imaging in the VISIUS Surgical Theatre.
Spinal Tech
Benvenue Medical has received 510(k) clearance from the U.S. Food and Drug Administration for its Kiva VCF system to treat vertebral compression fractures.
BioStructures announced the U.S. Food and Drug Administration has granted 510(k) clearance for Signafuse Bioactive Bone Graft Putty.
Tyber Medical announced it has formed a partnership with Magellan Capital Partners that will allow Magellan Capital Partners to provide financing services to Tyber Medical's partners.
Aurora Spine announced the first surgical implant of the company's ZIP ULTRA Minimally Invasive Interspinous Device in the United Kingdom.
Medtronic announced its total worldwide revenue for the third quarter of fiscal year 2014 is $4.163 billion, up slightly from its revenue during the same period last year, $4.027 billion.
PDL BioPharma and Paradigm Spine announced that they have entered into a credit agreement under which PDL will provide Paradigm with up to $75 million of secured debt financing.
Aurora Spine announced it has received U.S. Food and Drug Administration 510(k) clearance for sterile-packed titanium plasma spray coated spinal fusion implants.
OrthAlign announced that it has entered into an exclusive distribution agreement with Biomet Japan for its total knee arthroplasty technology — KneeAlign.
Arthrosurface announced that its HemiCAP technology has reached its 10-year milestone.
